Alliance Global Partners analyst Ben Haynor maintains T2 Biosystems (NASDAQ:TTOO) with a Neutral and lowers the price target from $2.2 to $1.5.
Alliance Global Partners Maintains Neutral on T2 Biosystems, Lowers Price Target to $1.5
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.